Skip to main content

Advertisement

Table 1 Patient characteristics

From: Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients

  Patients (n = 33)
Median age (years, range) 68.0 (49–82)
Gender
 Male 21 (63.6%)
 Female 12 (36.4%)
UICC-stage (TNM 7th ed.)
 IIIA 14 (42.4%)
 IIIB 19 (57.6%)
Histological type
 Squamous cell carcinoma 16 (48.5%)
 Adenocarcinoma 17 (51.5%)
Smoker status
 Non-smoker 8 (24.2%)
 Smoker 28 (75.8%)
Chemotherapy
 Cisplatin/Vinorelbine 10 (30.3%)
 Carboplatin/Paclitaxel 23 (69.7%)
Localisation
 Periphery 23 (69.7%)
 Central 10 (30.3%)
 Left 16 (48.5%)
 Right 17 (51.5%)
Mean total lung dose (Gy) 15.7 (8.2–24.43)
Mean V20 25.1 (12.0–45.01)
Mean V30 17.3 (6.4–34.27)